Last update 24 May 2024

PN-235

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
JNJ-2113, JNJ-77242113, JNJ-77242113-AAC
+ [1]
Target
Mechanism
IL-23R inhibitors(Interleukin 23 Receptor inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Erythrodermic psoriasisPhase 3
JP
09 Feb 2024
Generalized Pustular PsoriasisPhase 3
JP
09 Feb 2024
Plaque psoriasisPhase 3
US
12 Oct 2023
Plaque psoriasisPhase 3
US
12 Oct 2023
Plaque psoriasisPhase 3
US
12 Oct 2023
Plaque psoriasisPhase 3
CN
12 Oct 2023
Plaque psoriasisPhase 3
JP
12 Oct 2023
Plaque psoriasisPhase 3
JP
12 Oct 2023
Plaque psoriasisPhase 3
JP
12 Oct 2023
Plaque psoriasisPhase 3
AR
12 Oct 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
227
odwdqdxdvv(kmceikynbg) = rkwptfazon gewqvxwfzu (rlfmsfobih )
Positive
09 Mar 2024
Phase 2
255
JNJ-77242113 25 mg once daily
lejvhooapa(fusunpyjov) = ognzujtjwl qornueqwuc (bzxmmkqcow )
Met
Positive
08 Feb 2024
JNJ-77242113 25 mg twice daily
lejvhooapa(fusunpyjov) = ffhmyllsxl qornueqwuc (bzxmmkqcow )
Met
Phase 2
255
nrcqwpgoms(oypfttomso) = nxktiwpcsr yhwzswibkk (hxhuoupbra )
Met
Positive
04 Jul 2023
nrcqwpgoms(oypfttomso) = lhpjjszwwu yhwzswibkk (hxhuoupbra )
Met
Phase 2
255
miwurljidv(kryzpjakfb) = rqytauyelh pmslirvinf (uylyblvcoa )
Positive
04 Jul 2023
miwurljidv(kryzpjakfb) = sqxorjvzzj pmslirvinf (uylyblvcoa )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free